Podleśny-Drabiniok, Anna http://orcid.org/0000-0001-5009-2263
Novikova, Gloriia
Liu, Yiyuan
Dunst, Josefine http://orcid.org/0000-0003-0061-0901
Temizer, Rose http://orcid.org/0000-0002-1933-2588
Giannarelli, Chiara http://orcid.org/0000-0003-2473-6058
Marro, Samuele
Kreslavsky, Taras http://orcid.org/0000-0002-6672-1914
Marcora, Edoardo http://orcid.org/0000-0002-3829-4927
Goate, Alison Mary http://orcid.org/0000-0002-0576-2472
Article History
Received: 10 February 2023
Accepted: 16 February 2024
First Online: 6 March 2024
Competing interests
: A.M.G.: Scientific Advisory Board (SAB) Genentech; SAB Muna Therapeutics; S.M.: consultant Dorian Therapeutics, Turn Biotechnologies. C.G. is listed as an inventor on Tech 160808G PCT/US2022/017777 filed by the Icahn School of Medicine at Mount Sinai, which has no competing interest in this work. G.N. is an employee of Genentech, a member of the Roche group, and owns company stock. The remaining authors declare that they have no competing interests.